Advancing Diversity, Equity and Inclusion Through Technology
Event Information
About this Event
We will be discussing the disproportionate impacts of AI and other technologies on underrepresented groups, case studies of how we can use technology to advance DEI, and much more.
Our speakers:
Dr. Wendy Cukier, Founder, Diversity Institute, Ryerson University
Dr. Wendy Cukier is the Diversity Institute Founder, Academic Director of the Women Entrepreneurship Knowledge Hub and Research Lead of the Future Skills Centre. Dr. Wendy Cukier is one of Canada’s leading experts in disruptive technologies, innovation processes, and diversity and inclusion. The Diversity Institute works with partners on projects (including several with OCC) aimed at promoting diversity and inclusion in leadership and entrepreneurship. Wendy leads the Women Entrepreneurship Knowledge Hub, funded by the Government of Canada which promotes inclusive support for women and other diverse entrepreneurs. Wendy was also an integral part of the bid for the new $260m Ryerson-led Future Skills Centre, funded by the Government of Canada and now leads a program of research focused driving innovative approaches to bridges the skills gap. She has helped create and grow several successful startups and social ventures including Flybits, Think2Thing, the Madeleine Collective, and Growing North (now Green Iglu).
Phil De Luna, Program Director, National Research Council of Canada
Phil De Luna is currently leading a world-class 7-year $57M collaborative research program on Canada-made clean energy technology as a Program Director at the National Research Council of Canada. His mandate is to develop transformative technologies to help Canada achieve net-zero GHG emissions by 2050. His moonshot is to make renewable fuels and chemicals from air and water.
De Luna is a pioneering carbontech expert with experience spanning cutting-edge topics such as carbon capture and conversion technologies, clean hydrogen, and artificial intelligence for materials discovery. His research has been published in high-impact journals such as Nature and Science (>5000 citations in 5 years) and has been covered by mainstream media such as Newsweek, CBC, Forbes, Popular Science, etc.
